Drug Profile
Research programme: inflammation modulators - Inimex
Alternative Names: Cationic peptides for inflammation - Inimex; IDRs - Inimex; IMX 002; IMX 002 compounds; Innate Defense Regulators - Inimex; Product II programme - InimexLatest Information Update: 04 Nov 2017
Price :
$50
*
At a glance
- Originator Inimex Pharmaceuticals
- Class Small molecules
- Mechanism of Action Immunomodulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Inflammation; Psoriasis; Rheumatoid arthritis
Most Recent Events
- 04 Nov 2017 No recent reports of development identified for preclinical development in Inflammation in Canada
- 04 Nov 2017 No recent reports of development identified for preclinical development in Psoriasis in Canada
- 04 Nov 2017 No recent reports of development identified for preclinical development in Rheumatoid-arthritis in Canada